Ami Organics Share News - Latest Updates, Live News & More

Latest news about Ami Organics

AcutaaS Chemicals Reports Strong Q2 FY26 Results, MD Confident of 25% Annual Revenue Growth 1 day ago Yesterday

Acutaas Chemicals Limited reported robust Q2 FY26 results with revenue up 24.1% YoY to ₹306.20 crores, EBITDA up 94.8% to ₹95.30 crores, and PAT up 91.3% to ₹71.90 crores. The Advanced Pharmaceutical Intermediates segment grew by 27.4% YoY, while Specialty Chemicals grew by 7.3%. The company is expanding into Battery Chemicals and Semiconductors. Management remains confident of achieving approximately 25% revenue growth for the full year.

Acutaas Chemicals Reports Robust Q2 FY26 Results: Revenue Surges 25.7%, Net Profit Nearly Doubles 1 day ago Yesterday

ACUTAAS Chemicals Shareholders Approve Key Leadership Reappointments and Financial Statements Sep 25, 2025

Acutaas Chemicals Achieves Platinum Medal from EcoVadis, Ranking in Top 1% for Global Sustainability Aug 27, 2025

Acutaas Chemicals Elevates Abhishek Patel to Senior Management, Adjusts ESOS 2023 Post-Stock Split Jul 30, 2025

More news about Ami Organics

30Jul 25

Acutaas Chemicals Reports Strong Q1 Results with 17.3% Revenue Growth

Acutaas Chemicals Limited announced robust Q1 FY24 results with revenue up 17.3% YoY to ₹2,072.00 crore and net profit soaring 199.6% to ₹440.00 crore. EBITDA margin expanded by 785 basis points to 24.6%. The company's growth was driven by strong performance in Pharmaceutical Intermediates. Acutaas entered a joint venture in South Korea, strengthening its position in semiconductor markets. The company also invested in its subsidiary AAML and fully utilized the ₹99.10 crore raised through a preferential issue.

30Jul 25

Acutaas Chemicals Reports Strong Q1 FY26 Performance with 17.3% Revenue Growth

Acutaas Chemicals announced robust Q1 FY26 results with revenue up 17.3% to ₹2,072.00 crore and net profit soaring 199.6% to ₹440.00 crore. EBITDA margin expanded by 785 basis points to 24.6%. The company's Pharmaceutical Intermediates business drove growth, and both pharma facilities received PMDA GMP certification. A new joint venture in South Korea aims to strengthen its semiconductor market position. Acutaas fully utilized ₹99.10 crore from a preferential issue for capital expenditure and corporate purposes. The company projects 25% growth with improved margins for FY26.

30Jul 25

ACUTAAS Chemicals Reports Strong Q1 FY26 Results, MD Targets 25% Growth for FY26

ACUTAAS Chemicals Limited reported robust Q1 FY26 financial results with significant growth across key metrics. Revenue from operations increased by 17.3% to ₹2,072.00 crore, EBITDA grew by 72.4% to ₹509.00 crore, and net profit surged by 199.6% to ₹440.00 crore. The company's pharmaceutical intermediates business was the primary growth driver. Both pharmaceutical facilities received PMDA GMP certification. ACUTAAS entered a joint venture in South Korea to strengthen its position in the semiconductor market. The company's Managing Director expressed confidence in achieving 25% growth with improved margins for FY26.

30Jul 25

Acutaas Chemicals Reports Robust Q1 FY2026 Results with 72% EBITDA Growth

Acutaas Chemicals Limited announced impressive Q1 FY2026 results. Revenue from operations increased by 21% to ₹2,072.37 crore. EBITDA surged 72% to ₹509.00 crore, with margin expanding to 24.56%. Profit after tax grew by 199% to ₹440.11 crore. The company, formerly known as Ami Organics Limited, changed its name effective May 15, 2025. Two wholly-owned subsidiaries also underwent name changes. The Board of Directors approved these unaudited financial results on July 30, 2025.

25Jul 25

Acutaas Chemicals to Host Q1FY26 Earnings Conference Call on July 30

Acutaas Chemicals Limited (formerly AMI Organics) will host an earnings call on July 30, 2025, at 4:30 PM IST to discuss Q1FY26 financial results. Key executives participating include Naresh Patel (CMD), Abhishek Patel (VP Strategy), and Bhavin Shah (CFO). The call follows a board meeting to approve results. Universal and international toll-free dial-in numbers are provided. The trading window for designated persons will be closed from July 1, 2025, until 48 hours after results declaration.

23Jul 25

Acutaas Chemicals Invests Rs 49.99 Crores in Subsidiary, Eyes Semiconductor Specialty Chemicals Expansion

Acutaas Chemicals Limited has invested Rs 49.99 crores in its wholly-owned subsidiary, Acutaas Advance Material Limited (AAML), through a rights issue. The investment involves subscribing to 30,48,780 equity shares at Rs 164.00 per share. This is part of a larger plan to invest up to Rs 150.00 crores in AAML through loans and equity subscriptions. AAML, incorporated in September 2023, specializes in semiconductor specialty chemicals and has operations in India and South Korea. The investment aims to expand Acutaas Chemicals' presence in the growing semiconductor specialty chemicals market.

30Jun 25

Acutaas Chemicals' Subsidiary Forms Joint Venture in South Korea for Semiconductor Chemicals

Acutaas Chemicals' subsidiary Baml has entered into a joint venture agreement with South Korean company J & Materials. The venture will focus on manufacturing and selling specialty chemicals for the semiconductor industry, primarily in South Korea with plans for expansion. Baml is investing 30 billion Korean Won in the joint venture. The partnership aims to strengthen Acutaas Chemicals' position in the semiconductor industry and expand its market presence in South Korea.

27Jun 25

Acutaas Chemicals Enters Joint Venture for Semiconductor Specialty Chemicals in South Korea

Acutaas Chemicals has entered into a joint venture with J & Materials to create and market specialty chemicals for the semiconductor industry. The venture, with an investment of KRW 30 billion (₹190.00 crore), will initially focus on the South Korean market with plans for future expansion. This strategic move aims to capitalize on the growing demand for advanced chemicals in the semiconductor sector.

02May 25

AMI Organics Reports Strong FY25 Results, Anticipates 25% Revenue Growth in FY26

AMI Organics Limited reported robust financial results for FY25, with revenue crossing ₹1,000 crore, up 40.30% YoY. EBITDA increased by 80.60% to ₹232.00 crore, and PAT nearly doubled to ₹160.00 crore. The company announced a final dividend of ₹1.50 per share. AMI Organics plans to rebrand as Acutaas Chemicals Limited and targets 25% revenue growth in FY26. The company raised funds through preferential issue and QIP for expansion and is focusing on R&D, including development of electrolyte additives.

02May 25

AMI Organics Reports Robust Q4 and FY2025 Financial Performance, Declares Dividend, and Projects Strong FY26 Growth

AMI Organics Limited has reported significant growth in Q4 and FY2025. Q4 revenue increased by 37% to ₹308.50 crore, EBITDA grew 97% to ₹84.10 crore, and net profit doubled to ₹53.00 crore. FY2025 revenue exceeded ₹1000 crore, marking 45%+ growth. The company announced a final dividend of ₹1.50 per share and plans to change its name to Acutaas Chemicals Limited. A 25% revenue growth is projected for FY2026.